Category: Osteoporosis
North America Osteoporosis
-
United States Women’s Health Market By Drug (ACTONEL, YAZ, Yasmin, Yasminelle, FORTEO, Minastrin 24 Fe, Mirena, NuvaRing, ORTHO TRI-CY LO, Premarin, Prolia, Reclast/Aclasta, XGEVA, Zometa, Others), By Application (Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region and Competition, Opportunity, and Forecast, 2019-2029F
... Uterine Fibroids, Menopause, Polycystic Ovary Syndrome), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region and Competition, Opportunity, and Forecast, 2019-2029F United States Women’s Health Market was valued at USD 19.78 billion in 2023 ... Read More
-
Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Europe, Asia Pacific, Middle East & Africa) Viscosupplementation is an orthopedic treatment method used to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts ... Read More
-
North America Foot and Ankle Devices Market Size, Share & Industry Trends Analysis Report By Application (Trauma, Osteoarthritis, Rheumatoid Arthritis, Hammertoe, Osteoporosis, Neurological Disorders and Bunions), By Product, By Country and Growth Forecast, 2022 - 2028
... 2028 The North America Foot And Ankle Devices Market would witness market growth of 6.0% CAGR during the forecast period (2022-2028). The main drivers of the market growth include the aging population as well as ... Read More
-
Postmenopausal Osteoporosis Market, by Drug Class (Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors, Anabolic Class, Calcium Metabolism Modifiers, and Others (Calcitonin, Denosumab among Others)), by Route of Administration (Oral, Intravenous Route, and Subcutaneous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Osteoporosis is a ... Read More
-
Syringe Market, By Usage (Sterilizable/Reusable Syringes, Disposable Syringes, and Prefilled Syringes), By Application (Insulin Syringes, Botox, Osteoarthritis, Human Growth Hormone and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 A syringe is the tube with a plunger that usually connects to a needle. It is widely used to inject fluid into the body ... Read More
-
Viscosupplementation Market, by Treatment (Single Injection Treatment Cycle, Three Injection Treatment Cycle, and Five Injection Treatment Cycle), by Application (Knee Osteoarthritis, Hip Osteoarthritis, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Viscosupplementation is a treatment that helps in reducing the joint pain, and improves the functional condition of the osteoarthritic joint. It involves ... Read More
-
North America Osteoporosis Treatment Market, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator, Rank Ligand Inhibitor and Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), By Country (U.S. and Canada), Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Pharmacies and Others), By Country (U.S. and Canada), Trend Analysis, Competitive Market Share & Forecast, 2018-2028 North America Osteoporosis Treatment Market to Cross USD 10.25 Billion by 2028 North America Osteoporosis Treatment Market is growing ... Read More
Research Assistance
